Journal article · 2019 · Open access
The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury
Neurotoxicity Research, 36(1), 163–174 · Published 5 April 2019 · DOI 10.1007/s12640-019-00026-w
In brief
“The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury” is a 2019 journal article by Laura Brandolini and 9 co-authors, published in Neurotoxicity Research. OpenAlex counts 36 citations as of 21 November 2026, which puts it in the top 7% of works published in 2019 by citations. It is open access under a CC BY licence: the full text is free to read at Neurotoxicity Research.
- Citations
- 36
- Most cited in
- 2021 (7)
- Field-weighted impact
- 2.06
- References
- 61
- Authors
- 10
Abstract
The central nervous system (CNS) constitutively expresses complement (C) membrane receptors and complement proteins, including the component C5a. This is a crucial terminal effector of the C cascade, mostly involved in pain and neuroinflammatory conditions. Aberrant activation of C5a protein and its receptor C5aR has been reported to play a critical role in neurodegenerative diseases, with important clinical consequences. Here we have investigated the effects of DF3016A, a novel selective C5aR antagonist, able to penetrate the blood-brain barrier (BBB), on cortical neurons exposed to oxygen-glucose deprivation-reoxygenation (OGD/R), a neuroinflammation-related process. We demonstrated that a mild ischemic insult induces an early upregulation of C5aR associated with the over-production of pro-inflammatory cytokines and the over-expression of the transcriptional regulatory factor miR-181. Furthermore, we report the first experimental evidence of the effect of DF3016A, modulating complement component C5a, on neurons in a model of injury. Interestingly, DF3016A protects neuronal viability by restoring intracellular calcium levels, thus opposing the increase in pro-inflammatory cytokine levels and miR-181 expression. Based on our results, we suggest that DF3016A is a novel C5aR antagonist promoting protective effects against OGD/R-induced damage that could be a new therapeutic approach to controlling CNS neuroinflammatory conditions.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Brandolini, L., Grannonico, M., Bianchini, G., Colanardi, A., Sebastiani, P., Paladini, A., Piroli, A., Allegretti, M., Varrassi, G., & Di Loreto, S. (2019). The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury. Neurotoxicity Research, 36(1), 163–174. https://doi.org/10.1007/s12640-019-00026-w
MLA 9
Brandolini, Laura, et al. “The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury.” Neurotoxicity Research, vol. 36, no. 1, 2019, pp. 163–174. https://doi.org/10.1007/s12640-019-00026-w.
Chicago
Brandolini, Laura, Marta Grannonico, Gianluca Bianchini, Alessia Colanardi, Pierluigi Sebastiani, Antonella Paladini, Alba Piroli, Marcello Allegretti, Giustino Varrassi, and Silvia Di Loreto. 2019. “The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury.” Neurotoxicity Research 36 (1): 163–174. https://doi.org/10.1007/s12640-019-00026-w.
Harvard
Brandolini, L. et al. (2019) ‘The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury’, Neurotoxicity Research, 36(1), pp. 163–174. doi:10.1007/s12640-019-00026-w.
IEEE
L. Brandolini et al., “The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury,” Neurotoxicity Research, vol. 36, no. 1, pp. 163–174, 2019, doi: 10.1007/s12640-019-00026-w.
BibTeX
@article{brandolini2019novel,
title = {{The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury}},
author = {Brandolini, Laura and Grannonico, Marta and Bianchini, Gianluca and Colanardi, Alessia and Sebastiani, Pierluigi and Paladini, Antonella and Piroli, Alba and Allegretti, Marcello and Varrassi, Giustino and Di Loreto, Silvia},
journal = {Neurotoxicity Research},
year = {2019},
volume = {36},
number = {1},
pages = {163--174},
doi = {10.1007/s12640-019-00026-w},
url = {https://doi.org/10.1007/s12640-019-00026-w}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 3 | |
| 2020 | 6 | |
| 2021 | 7 | |
| 2022 | 7 | |
| 2023 | 4 | |
| 2024 | 5 | |
| 2025 | 2 | |
| 2026 | 2 |
Its field-weighted citation impact is 2.06: it has been cited 2.06 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- C5a
- neuroinflammation
- cerebral ischemia
- oxygen-glucose deprivation/reoxygenation
- cortical neurons
- inflammatory cytokines
- miR-181
- intracellular calcium
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Brandolini, L., Grannonico, M., Bianchini, G., Colanardi, A., Sebastiani, P., Paladini, A., Piroli, A., Allegretti, M., Varrassi, G., & Di Loreto, S. (2019). The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury. Neurotoxicity Research, 36(1), 163–174. https://doi.org/10.1007/s12640-019-00026-w
How many times has this paper been cited?
36 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Neurotoxicity Research: sign in and open the PDF from this page.
Who wrote this paper?
Laura Brandolini, Marta Grannonico, Gianluca Bianchini, Alessia Colanardi, Pierluigi Sebastiani, Antonella Paladini, Alba Piroli, Marcello Allegretti, Giustino Varrassi, Silvia Di Loreto.
What is the DOI of this paper?
10.1007/s12640-019-00026-w, permanently at https://doi.org/10.1007/s12640-019-00026-w. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.